Hypertension Diagnostics (Hypertension Diagnostics) Debt-to-Revenue : N/A (As of Sep. 2019)

View and export this data going back to 1998. Start your Free Trial

What is Hypertension Diagnostics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Hypertension Diagnostics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $4.69 Mil. Hypertension Diagnostics's annualized Revenue for the quarter that ended in Sep. 2019 was $0.00 Mil.

Hypertension Diagnostics Debt-to-Revenue Historical Data

The historical data trend for Hypertension Diagnostics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypertension Diagnostics Debt-to-Revenue Chart

Hypertension Diagnostics Annual Data

Trend

Jun06

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Dec16

Dec17

Dec18

Debt-to-Revenue

Get a 7-Day Free Trial

N/A

0.19

1.18

1.20

1.24

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
Debt-to-Revenue	Get a 7-Day Free Trial															N/A	N/A	N/A	N/A	N/A

Competitive Comparison of Hypertension Diagnostics's Debt-to-Revenue

For the Shell Companies subindustry, Hypertension Diagnostics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics's Debt-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's Debt-to-Revenue falls into.

Hypertension Diagnostics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Hypertension Diagnostics's Debt-to-Revenue for the fiscal year that ended in Dec. 2018 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	4.685)	/	3.792
	=	1.24

Hypertension Diagnostics's annualized Debt-to-Revenue for the quarter that ended in Sep. 2019 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	4.685)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2019) Revenue data.

Hypertension Diagnostics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hypertension Diagnostics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.